[HTML][HTML] Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung …

P Lin, W Cheng, X Qi, P Zhang, J Xiong… - International Journal of …, 2024 - mdpi.com
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS G12C-Mutated Lung Adenocarcinoma …

P Lin, W Cheng, X Qi, P Zhang… - International Journal of …, 2024 - search.ebscohost.com
The Kirsten rat sarcoma viral oncogene homolog (KRAS)< sup> G12C mutation is prevalent
in lung adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis …

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma

P Lin, W Cheng, X Qi, P Zhang… - … journal of molecular …, 2024 - pubmed.ncbi.nlm.nih.gov
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma

P Lin, W Cheng, X Qi, P Zhang… - International Journal of …, 2024 - archive.pcbmb.org
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

[HTML][HTML] Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung …

P Lin, W Cheng, X Qi, P Zhang, J Xiong… - International Journal of …, 2024 - ncbi.nlm.nih.gov
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma

P Lin, W Cheng, X Qi, P Zhang, J Xiong… - International Journal of …, 2024 - europepmc.org
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

[PDF][PDF] Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung …

P Lin, W Cheng, X Qi, P Zhang, J Xiong, J Li - Int. J. Mol. Sci - pdfs.semanticscholar.org
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

[PDF][PDF] Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung …

P Lin, W Cheng, X Qi, P Zhang, J Xiong, J Li - Int. J. Mol. Sci - archive.pcbmb.org
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung …

P Lin, W Cheng, X Qi, P Zhang, J Xiong… - International Journal of …, 2024 - europepmc.org
The Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutation is prevalent in lung
adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While …